₹ 4.2 Cr
Volume Transacted
(Nov 7, 2024)
15.6 K
Stocks Traded
(Nov 7, 2024)
Last Updated on: Nov 08, 2024
Mankind Pharma Ltd
NSE: MANKIND
YEARHIGH
₹ 2882.75
Last updated on: Nov 07, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
07 Nov 2024 | 2726.45 | 2750.1 | 2758.7 | 2716 |
06 Nov 2024 | 2750.1 | 2850.05 | 2882.75 | 2708.6 |
05 Nov 2024 | 2714.4 | 2746.6 | 2746.6 | 2652.55 |
04 Nov 2024 | 2734.95 | 2688.55 | 2751 | 2666.4 |
01 Nov 2024 | 2690.55 | 2724.95 | 2731.8 | 2650.85 |
31 Oct 2024 | 2666.6 | 2627.8 | 2730 | 2594.45 |
30 Oct 2024 | 2628.25 | 2574.75 | 2651 | 2556.45 |
29 Oct 2024 | 2527.35 | 2421.45 | 2539.2 | 2414.1 |
28 Oct 2024 | 2428.6 | 2449.95 | 2468.9 | 2405 |
25 Oct 2024 | 2456.95 | 2510.05 | 2526.9 | 2450 |
Date | Price (₹) |
---|---|
07 Nov 2024 | 2726.45 |
06 Nov 2024 | 2750.1 |
05 Nov 2024 | 2714.4 |
04 Nov 2024 | 2734.95 |
01 Nov 2024 | 2690.55 |
31 Oct 2024 | 2666.6 |
30 Oct 2024 | 2628.25 |
29 Oct 2024 | 2527.35 |
28 Oct 2024 | 2428.6 |
25 Oct 2024 | 2456.95 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Mankind Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Mankind Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Mankind Pharma receives reaffirmation in credit rating from CRISIL
Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under: Commerci...
06 Nov 202413:15
Mankind Pharma hits life high after Q2 PAT jumps 30% YoY to Rs 653 cr
Profit before tax was at Rs 849.32 crore in Q2 FY25, registering a growth of 32.5% from Rs...
06 Nov 202410:03
Mankind Pharma Ltd spurts 0.01%, up for fifth straight session
Mankind Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 26...
04 Nov 202413:00
Mankind Pharma Ltd spurts 3.89%
Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs...
31 Oct 202413:05
Mankind Pharma to convene board meeting
Mankind Pharma will hold a meeting of the Board of Directors of the Company on 5 November ...
25 Oct 202416:07
Mankind Pharma receives ratings action from ICRA
Mankind Pharma has received reaffirmation in credit rating for non-convertible debentures ...
30 Sep 202417:14
FAQs for 52 Week High of Mankind Pharma Ltd
What is the significance of Mankind Pharma Ltd reaching its 52-week high?
Why do investors monitor Mankind Pharma Ltd 52-week high?
Is Mankind Pharma Ltd a good buy when it hits its 52-week high?
What should I consider before investing in Mankind Pharma Ltd at its 52-week high?
Can Mankind Pharma Ltd stock price continue to rise after reaching its 52-week high?
Unlimited trading at just
Rs. 199*